EX-FILING FEES 5 ex_442697.htm EXHIBIT FILING FEES ex_442697.htm

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-3

 

(Form Type)

 

AcelRx Pharmaceuticals, Inc.

 

(Exact Name of Registrant as Specified in its Charter)

 

 

Table 1: Newly Registered Securities

 

 

 

Security

Type

Security Class

Title

Fee

Calculation

or Carry

Forward

Rule

Amount

Registered

Proposed

Maximum

Offering Price

Per Unit(1)

Maximum

Aggregate

Offering Price(1)

Fee Rate

Amount of

Registration

Fee(1)

Fees to Be

Paid

Equity

Common stock,

par value $0.001

per share

457(c)

 81,150(2)

$1.895

$153,780

$0.00011020

$17
 

Total Offering Amounts

  

$153,780

  

$17
 

Total Fee Offsets

      

—
 

Net Fee Due

      

$17

 

(1)

Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act of 1933, as amended. The price per share and aggregate offering price are based on the average of the high and low prices of the Registrant’s common stock on November 9, 2022, as reported on The Nasdaq Global Market.

 

(2)

Consists of 81,150 shares of the Registrant’s common stock registered for resale by the selling stockholder named in this registration statement. Pursuant to Rule 416 under the Securities Act of 1933, as amended, this registration statement shall also cover any additional shares of common stock resulting from stock splits, stock dividends or similar transactions.